Literature DB >> 24406315

Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI.

Adriana Parrella1, Michael Gold1, Annette Braunack-Mayer2, Peter Baghurst1, Helen Marshall1.   

Abstract

Passive reporting of adverse events following immunization (AEFI) by consumers or healthcare professionals is the primary mechanism for post-marketing surveillance of vaccine safety. Although recent initiatives have promoted consumer reporting, there is a lack of research concerning consumer reporters. Computer assisted telephone interviews (CATI) were conducted in 2011 of a cross-sectional, random, general population sample of 191 South Australian parents who stated that their children had previously experienced an AEFI. We compared awareness of surveillance, vaccine safety opinions, and demographics of parents reporting an AEFI to either healthcare professionals or surveillance authorities with those who did not report their children's AEFI. Multivariate regression analyses measured: the association between reporting and safety views; and demographic predictors of reporting an AEFI. Reporting an AEFI to a healthcare professional or a surveillance authority was not significantly associated with awareness of a surveillance system. AEFI reporters, when compared with non-reporters, were more likely to be Australian-born (OR = 4.58, [1.64, 12.78], P = 0.004); were associated with the perception that a serious reaction was more likely to occur at their children's last immunization (OR = 2.54 [95%CI 1.22, 5.30], P = 0.013); and were less accepting of the risk of febrile convulsion, (OR = 3.59 [95%CI 1.50, 8.57], P = 0.004). Although reporting an AEFI was not associated with awareness of surveillance or most socio-demographics, the results suggest some difference in safety opinions. Further studies are required to ascertain if these differences pre-date the occurrence of an AEFI or are a consequence of the AEFI and how consumers can contribute further to vaccine safety surveillance.

Entities:  

Keywords:  adverse event following immunization; health survey; parent; surveillance; vaccine safety attitudes

Mesh:

Year:  2014        PMID: 24406315      PMCID: PMC4130288          DOI: 10.4161/hv.27459

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  29 in total

1.  Defining 'surveillance' in drug safety.

Authors:  Jeffrey K Aronson; Manfred Hauben; Andrew Bate
Journal:  Drug Saf       Date:  2012-05-01       Impact factor: 5.606

Review 2.  The globalization of risk and risk perception: why we need a new model of risk communication for vaccines.

Authors:  Heidi Larson; Pauline Brocard Paterson; Ngozi Erondu
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

3.  Who is unlikely to report adverse events after vaccinations to the Vaccine Adverse Event Reporting System (VAERS)?

Authors:  Michael M McNeil; Rongxia Li; Susanne Pickering; Theresa M Real; Philip J Smith; Michael R Pemberton
Journal:  Vaccine       Date:  2013-04-16       Impact factor: 3.641

4.  Public perspectives on consent for the linkage of data to evaluate vaccine safety.

Authors:  Jesia G Berry; Michael S Gold; Philip Ryan; Katherine M Duszynski; Annette J Braunack-Mayer
Journal:  Vaccine       Date:  2012-04-27       Impact factor: 3.641

5.  Agreement between medical record and parent report for evaluation of childhood febrile seizures.

Authors:  Bradley K Ackerson; Lina S Sy; Janis F Yao; T Craig Cheetham; Ana M Espinosa-Rydman; Tonia L Jones; Steven J Jacobsen
Journal:  Vaccine       Date:  2013-04-11       Impact factor: 3.641

6.  Parental perspectives of vaccine safety and experience of adverse events following immunisation.

Authors:  Adriana Parrella; Michael Gold; Helen Marshall; Annette Braunack-Mayer; Peter Baghurst
Journal:  Vaccine       Date:  2013-02-17       Impact factor: 3.641

7.  First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.

Authors:  Geneviève Durrieu; Aurore Palmaro; Laure Pourcel; Céline Caillet; Angeline Faucher; Alexis Jacquet; Shéhérazade Ouaret; Marie Christine Perault-Pochat; Carmen Kreft-Jais; Anne Castot; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606

8.  Annual report: Surveillance of adverse events following immunisation in Australia, 2011.

Authors:  Deepika Mahajan; Jane Cook; Aditi Dey; Kristine Macartney; Rob I Menzies
Journal:  Commun Dis Intell Q Rep       Date:  2012-12-31

9.  What can we learn from parents about enhancing participation in pharmacovigilance?

Authors:  Janine Arnott; Hannah Hesselgreaves; Anthony J Nunn; Matthew Peak; Munir Pirmohamed; Rosalind L Smyth; Mark A Turner; Bridget Young
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

10.  Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study.

Authors:  Adriana Parrella; Annette Braunack-Mayer; Michael Gold; Helen Marshall; Peter Baghurst
Journal:  BMC Health Serv Res       Date:  2013-08-15       Impact factor: 2.655

View more
  8 in total

1.  An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination.

Authors:  Kumanan Wilson; Katherine M Atkinson; Jacqueline Westeinde; Cameron Bell; Kim Marty; Dean Fergusson; Shelley L Deeks; Natasha Crowcroft; Julie A Bettinger
Journal:  Hum Vaccin Immunother       Date:  2016-02-23       Impact factor: 3.452

2.  Consumer reporting of adverse events following immunization.

Authors:  Hazel J Clothier; Gowri Selvaraj; Mee Lee Easton; Georgina Lewis; Nigel W Crawford; Jim P Buttery
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 3.  Big Data Usage Patterns in the Health Care Domain: A Use Case Driven Approach Applied to the Assessment of Vaccination Benefits and Risks. Contribution of the IMIA Primary Healthcare Working Group.

Authors:  H Liyanage; S de Lusignan; S-T Liaw; C E Kuziemsky; F Mold; P Krause; D Fleming; S Jones
Journal:  Yearb Med Inform       Date:  2014-08-15

Review 4.  Factors affecting patient reporting of adverse drug reactions: a systematic review.

Authors:  Rania Al Dweik; Dawn Stacey; Dafna Kohen; Sanni Yaya
Journal:  Br J Clin Pharmacol       Date:  2016-11-25       Impact factor: 4.335

Review 5.  Participant-centred active surveillance of adverse events following immunisation: a narrative review.

Authors:  Patrick Cashman; Kristine Macartney; Gulam Khandaker; Catherine King; Michael Gold; David N Durrheim
Journal:  Int Health       Date:  2017-05-01       Impact factor: 2.473

6.  Adverse Events Following Measles-Mumps-Rubella-Varicella Vaccination and the Case of Seizures: A Post Marketing Active Surveillance in Puglia Italian Region, 2017-2018.

Authors:  Pasquale Stefanizzi; Paolo Stella; Domenica Ancona; Katia Nicoletta Malcangi; Francesco Paolo Bianchi; Sara De Nitto; Davide Ferorelli; Cinzia Annatea Germinario; Silvio Tafuri
Journal:  Vaccines (Basel)       Date:  2019-10-07

7.  Consumer opinions on adverse events associated with medicines and vaccines.

Authors:  Parisa Aslani; Kim Hamrosi; Vivien Tong; Timothy F Chen; Jane Cook; Romano Fois; Theresa McGarry; Carter Moore; Rodney Peters; Sarah Spagnardi; Karen Whitelock
Journal:  Patient Prefer Adherence       Date:  2018-07-31       Impact factor: 2.711

8.  Parental Declaration of Adverse Event Following Immunization in a Cross-Sectional Study in Poland.

Authors:  Kamil Barański; Maksymilian Gajda; Bogumiła Braczkowska; Małgorzata Kowalska
Journal:  Int J Environ Res Public Health       Date:  2019-10-22       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.